
Vincent Gallet
Journalist
Barclays strengthens its Cash Equities team in Japan
Barclays announced the appointment of Takeo Kamai as head of High-Touch Sales Trading in Japan, and of Warren Kim within its Cash Equities division. Based in Tokyo, they will join the High-Touch Sales Trading team in Asia-Pacific (APAC), led by Joseph Lee.
September 07, 2026 at 06:14 pm
Volkswagen prepares a divestment of its Osnabrück site
Volkswagen said on Monday it has reached an agreement with the state (Land) of Lower Saxony and Israeli investment firm Aurelius Capital regarding the possible sale of Volkswagen Osnabrück GmbH, with the aim of preserving the Osnabrück site and most of its jobs over the long term.
September 07, 2026 at 03:43 pm

Standard Life trading higher after first-half results
Standard Life is up 1.2% at 944 GBX in London, after reporting IFRS adjusted operating profit up 25% to 563 MGBP for the first six months of 2026, beating the consensus by 4% according to Panmure Liberum, which points to the impact of cost savings and operating leverage.
September 07, 2026 at 12:42 pm

Deutsche Bank raises its price target on Nemetschek
Deutsche Bank reiterates its 'buy' rating and lifts its price target on Nemetschek to 80 EUR from 75 EUR, following last week's European TMT conference in London, during which it hosted executives from the German software publisher.
September 07, 2026 at 11:30 am
Derichebourg launches a senior green bond offering
Environmental services group Derichebourg has announced the launch of an offering with an aggregate principal amount of 800m of senior green bonds, consisting of senior notes maturing in 2031 and senior notes maturing in 2033.
September 07, 2026 at 11:12 am
Novartis pelacarsen fails Phase III trial
Novartis said late Friday that its Phase III Lp(a)HORIZON trial of pelacarsen failed, as the drug did not meet its primary endpoint of reducing the risk of cardiovascular events (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke and urgent coronary revascularization requiring hospitalization) versus placebo.
September 07, 2026 at 10:47 am

A green light from the US FDA for AstraZeneca in breast cancer
AstraZeneca said late Friday that the United States has approved its Etcamah (camizestrant), in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib, or ribociclib), for the first-line treatment of advanced hormone receptor-positive (HR-positive) breast cancer.
September 07, 2026 at 09:33 am
Oddo BHF stays positive on Commerzbank as the UniCredit file moves forward
Oddo BHF reiterates its 'outperform' rating and its price target of 45 on Commerzbank, as we enter, in its view, a decisive phase of the 'UCG-CBK M&A saga' in early September 2026.
September 04, 2026 at 05:23 pm
Pratt & Whitney (RTX) invests in a site in Poland
Pratt & Whitney, RTX's aircraft engine unit, says it is investing $25m (95 MPLN) to expand its manufacturing plant in Niepolomice, Poland, dedicated to producing complex tubular assemblies for commercial and military engines.
September 04, 2026 at 03:50 pm

Kerlink teams up with DataPrint in a distribution partnership
Kerlink announced the signing of a distribution partnership with DataPrint, enabling Kerlink to broaden its presence across the entire IoT value chain and strengthen its commercial coverage throughout France, while further consolidating its ecosystem of trusted distributors.
September 04, 2026 at 03:26 pm
GTT lifted by a Berenberg upgrade to buy
GTT (Gaztransport & Technigaz) jumps 3.6%, to 215, lifted by an upgrade at Berenberg from "hold" to "buy", with a price target raised from 190 to 245, the German bank still seeing upside potential despite the stock's strong performance since the start of the year.
September 04, 2026 at 11:37 am
Morgane Aganian-Gnakpa appointed deputy CEO of Societe Generale Assurances
Societe Generale announced the appointment of Morgane Aganian-Gnakpa as deputy chief executive officer of Societe Generale Assurances, in charge of the Bancassurance and Digital Development division, effective October 1, 2026.
September 04, 2026 at 11:20 am
Discover our authors
Chief Editor
Journalist
Journalist
Analyst
Journalist
- Stock Market
- Our authors
- Vincent Gallet



















